Multidrug resistance in the protozoan parasite Entamoeba histolytica

E. Orozco, C. López, C. Gómez, D. G. Pérez, L. Marchat, C. Bañuelos, D. M. Delgadillo

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

In this review we discuss the mechanisms and molecules involved in the multidrug resistance (MDR) of the protozoan parasite Entamoeba histolytica. Drug resistant mutants exhibited the main characteristics presented by the MDR mammalian cells. They showed cross-resistance to several unrelated drugs that is reverted by calcium channel blockers. MDR phenotype in E. histolytica is regulated at a transcriptional level by the EhPgp1 gene, which is constitutively expressed and by the EhPgp5 gene, whose expression is induced in the presence of the drug. Transcription factors participate in the expression regulation of these genes. After over transcription, the EhPgp genes are amplified, cooperating to produce the MDR phenotype. Post-transcriptional mechanisms such as mRNA stability seem to be involved in this phenomenon. As for other mdr gene products, the EhPGP5 protein functions as a chloride current inductor or as a regulator of cellular regulatory volume decrease. © 2002 Elsevier Science Ireland Ltd. All rights reserved.
Original languageAmerican English
Pages (from-to)353-359
Number of pages317
JournalParasitology International
DOIs
StatePublished - 1 Dec 2002

Fingerprint

Entamoeba histolytica
Multiple Drug Resistance
Parasites
Pharmaceutical Preparations
Phenotype
RNA Stability
Calcium Channel Blockers
Gene Expression Regulation
Ireland
Genes
Chlorides
Transcription Factors
Gene Expression
Proteins

Cite this

@article{c75b5d1239c849cda808e10abaa4235b,
title = "Multidrug resistance in the protozoan parasite Entamoeba histolytica",
abstract = "In this review we discuss the mechanisms and molecules involved in the multidrug resistance (MDR) of the protozoan parasite Entamoeba histolytica. Drug resistant mutants exhibited the main characteristics presented by the MDR mammalian cells. They showed cross-resistance to several unrelated drugs that is reverted by calcium channel blockers. MDR phenotype in E. histolytica is regulated at a transcriptional level by the EhPgp1 gene, which is constitutively expressed and by the EhPgp5 gene, whose expression is induced in the presence of the drug. Transcription factors participate in the expression regulation of these genes. After over transcription, the EhPgp genes are amplified, cooperating to produce the MDR phenotype. Post-transcriptional mechanisms such as mRNA stability seem to be involved in this phenomenon. As for other mdr gene products, the EhPGP5 protein functions as a chloride current inductor or as a regulator of cellular regulatory volume decrease. {\circledC} 2002 Elsevier Science Ireland Ltd. All rights reserved.",
author = "E. Orozco and C. L{\'o}pez and C. G{\'o}mez and P{\'e}rez, {D. G.} and L. Marchat and C. Ba{\~n}uelos and Delgadillo, {D. M.}",
year = "2002",
month = "12",
day = "1",
doi = "10.1016/S1383-5769(02)00041-7",
language = "American English",
pages = "353--359",
journal = "Parasitology International",
issn = "1383-5769",
publisher = "Elsevier Ireland Ltd",

}

Multidrug resistance in the protozoan parasite Entamoeba histolytica. / Orozco, E.; López, C.; Gómez, C.; Pérez, D. G.; Marchat, L.; Bañuelos, C.; Delgadillo, D. M.

In: Parasitology International, 01.12.2002, p. 353-359.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Multidrug resistance in the protozoan parasite Entamoeba histolytica

AU - Orozco, E.

AU - López, C.

AU - Gómez, C.

AU - Pérez, D. G.

AU - Marchat, L.

AU - Bañuelos, C.

AU - Delgadillo, D. M.

PY - 2002/12/1

Y1 - 2002/12/1

N2 - In this review we discuss the mechanisms and molecules involved in the multidrug resistance (MDR) of the protozoan parasite Entamoeba histolytica. Drug resistant mutants exhibited the main characteristics presented by the MDR mammalian cells. They showed cross-resistance to several unrelated drugs that is reverted by calcium channel blockers. MDR phenotype in E. histolytica is regulated at a transcriptional level by the EhPgp1 gene, which is constitutively expressed and by the EhPgp5 gene, whose expression is induced in the presence of the drug. Transcription factors participate in the expression regulation of these genes. After over transcription, the EhPgp genes are amplified, cooperating to produce the MDR phenotype. Post-transcriptional mechanisms such as mRNA stability seem to be involved in this phenomenon. As for other mdr gene products, the EhPGP5 protein functions as a chloride current inductor or as a regulator of cellular regulatory volume decrease. © 2002 Elsevier Science Ireland Ltd. All rights reserved.

AB - In this review we discuss the mechanisms and molecules involved in the multidrug resistance (MDR) of the protozoan parasite Entamoeba histolytica. Drug resistant mutants exhibited the main characteristics presented by the MDR mammalian cells. They showed cross-resistance to several unrelated drugs that is reverted by calcium channel blockers. MDR phenotype in E. histolytica is regulated at a transcriptional level by the EhPgp1 gene, which is constitutively expressed and by the EhPgp5 gene, whose expression is induced in the presence of the drug. Transcription factors participate in the expression regulation of these genes. After over transcription, the EhPgp genes are amplified, cooperating to produce the MDR phenotype. Post-transcriptional mechanisms such as mRNA stability seem to be involved in this phenomenon. As for other mdr gene products, the EhPGP5 protein functions as a chloride current inductor or as a regulator of cellular regulatory volume decrease. © 2002 Elsevier Science Ireland Ltd. All rights reserved.

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0036888209&origin=inward

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=0036888209&origin=inward

U2 - 10.1016/S1383-5769(02)00041-7

DO - 10.1016/S1383-5769(02)00041-7

M3 - Article

SP - 353

EP - 359

JO - Parasitology International

JF - Parasitology International

SN - 1383-5769

ER -